Xeriant (XERI) EBITDA (2010 - 2026)

Xeriant has disclosed EBITDA across 17 years of filings, most recently posting $120997.0 for Q1 2026.

• EBITDA for Q1 2026 came in at $120997.0, up 126.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 million (up 20.86% YoY), and the FY2025 annual result was -$1.4 million, up 28.35% from the prior year.
• EBITDA came in at $120997.0 for Q1 2026 at Xeriant, up from -$231062.0 in the prior quarter.
• In the past five years, EBITDA ranged from a high of $120997.0 in Q1 2026 to a low of -$2.4 million in Q2 2024.
• The 5-year median for EBITDA is -$387240.0 (2023), against an average of -$581748.7.
• Across the five-year window, EBITDA surged 128.6% in 2024 and sank 577.92% in 2025, its largest moves.
• Xeriant's EBITDA stood at -$539019.0 in 2022, then surged by 36.93% to -$339943.0 in 2023, then surged by 126.83% to $91212.0 in 2024, then sank by 353.32% to -$231062.0 in 2025, then soared by 152.37% to $120997.0 in 2026.
• The last three EBITDA figures came in at $120997.0 (Q1 2026), -$231062.0 (Q4 2025), and -$304075.0 (Q3 2025), per Business Quant data.